Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
FCPM III SERVICES B.V. (CIK 2013410) reported $722.2M across 9 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: NAMS ($294.5M, 40.77%), DYN ($84.2M, 11.66%), VOR ($73.5M, 10.17%), ENGN ($65.6M, 9.08%), ($65.6M, 9.08%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $294.5M | 40.77% | 9.2M | Hold |
| 2 | DYN | DYNE THERAPEUTICS INC | $84.2M | 11.66% | 4.6M | Trimmed |
| 3 | VOR | VOR BIOPHARMA INC | $73.5M | 10.17% | 4.1M | Added |
| 4 | ENGN | ENGENE HOLDINGS INC | $65.6M | 9.08% | 9.6M | Hold |
| 5 | MAPLIGHT THERAPEUTICS INC | $65.6M | 9.08% | 3.2M | Hold | |
| 6 | GLTO | DAMORA THERAPEUTICS INC | $63.2M | 8.75% | 2.4M | New |
| 7 | CBIO | CRESCENT BIOPHARMA INC. | $30.8M | 4.27% | 1.7M | Hold |
| 8 | REPL | REPLIMUNE GROUP INC | $21.5M | 2.97% | 2.8M | Hold |
| 9 | BCYC | BICYCLE THERAPEUTICS PLC | $16.1M | 2.23% | 3.5M | Hold |
| 10 | ENGNW | ENGENE HOLDINGS INC | $7.3M | 1.01% | 2.9M | Hold |
| 11 | RAPT | RAPT THERAPEUTICS INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-03-31